The partnership will also support digital transformation, institutional capacity-building, and integrated health systems that promote sustainability and national ownership.
The new infrastructure enables the organization to procure, store, and rapidly deploy critical medical supplies when outbreaks threaten African communities.
The newly launched CDR tackles this fundamental challenge by establishing a secure, interoperable platform that brings together surveillance information, laboratory results, and programme data from both national and regional systems.
The Democratic Republic of the Congo bore the heaviest burden, accounting for 96% of reported cases and 97% of deaths.
The partnership enables Africa CDC to reinforce its central role in advancing continental priorities, including its 2023–2027 Strategic Plan and the Africa Health Security and Sovereignty (AHSS) agenda.
The continued partnership aims to strengthen research focused on developing effective therapeutic options for mpox, a viral disease that currently lacks a dedicated antiviral treatment.
The study analysed more than 187,000 laboratory test results from 205 laboratories located in 14 African countries, including Nigeria, using samples collected between 2016 and 2019.
The partnership is built on five guiding principles: Member State Ownership and Leadership, Equity and Access, Sustainability and Sovereignty, Transparency and Accountability, and Innovation for Impact.
The event will take place on December 3 at the Accra International Conference Centre, immediately following the opening ceremony of the International Conference on AIDS and STIs in Africa (ICASA 2025).
The approved funding will help countries build systems that keep communities safe, particularly in cross-border areas where health risks are highest.